Cargando…

Incidence of Placebo Adverse Events in Randomized Clinical Trials of Targeted and Immunotherapy Cancer Drugs in the Adjuvant Setting: A Systematic Review and Meta-analysis

IMPORTANCE: Several reports have associated the placebo effect with objective response and improvement of a clinical condition in oncology, but only a few studies have analyzed the adverse events (AEs) in the placebo groups of the clinical trials. OBJECTIVE: To determine the incidence of placebo AEs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chacón, Matías Rodrigo, Enrico, Diego Hernán, Burton, Jeannette, Waisberg, Federico Daniel, Videla, Viviana Marina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2018
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324542/ https://www.ncbi.nlm.nih.gov/pubmed/30646278 http://dx.doi.org/10.1001/jamanetworkopen.2018.5617

Ejemplares similares

Uncommon Subtypes of Malignant Melanomas: A Review Based on Clinical and Molecular Perspectives
por: Chacón, Matías, et al.
Publicado: (2020)

Aluminium adjuvants and adverse events in sub-cutaneous allergy immunotherapy
por: Exley, Christopher
Publicado: (2014)

Association of Lipoprotein(a) Levels With Incidence of Major Adverse Limb Events
por: Guédon, Alexis F., et al.
Publicado: (2022)

Frequency of Adverse Events in the Placebo Arms of COVID-19 Vaccine Trials: A Systematic Review and Meta-analysis
por: Haas, Julia W., et al.
Publicado: (2022)

Four‐year incidence of major adverse cardiovascular events in patients with atherosclerosis and atrial fibrillation
por: Miao, Benjamin, et al.
Publicado: (2020)

Short-course radiotherapy for rectal cancer: real-world evidence in Argentina
por: Tissera, Natalia S, et al.
Publicado: (2023)

Extended Follow-Up of Chronic Immune-Related Adverse Events Following Adjuvant Anti–PD-1 Therapy for High-Risk Resected Melanoma
por: Goodman, Rachel S., et al.
Publicado: (2023)

Gastrointestinal adverse events of immunotherapy
por: Cappello, Giovanni, et al.
Publicado: (2021)

Genetics of Adverse Reactions to Haloperidol in a Mouse Diallel: A Drug–Placebo Experiment and Bayesian Causal Analysis
por: Crowley, James J., et al.
Publicado: (2014)

First-line cisplatin, docetaxel, and cetuximab for patients with recurrent or metastatic head and neck cancer: A multicenter cohort study
por: Falco, Agustín, et al.
Publicado: (2022)

Association of Immune-Related Adverse Events, Hospitalization, and Therapy Resumption With Survival Among Patients With Metastatic Melanoma Receiving Single-Agent or Combination Immunotherapy
por: Watson, Alexander S., et al.
Publicado: (2022)

Adverse Events Associated With the Use of Sipuleucel-T Reported to the US Food and Drug Administration’s Adverse Event Reporting System, 2010-2017
por: Dores, Graça M., et al.
Publicado: (2019)

Cutaneous Adverse Events to Targeted Therapies and Immunotherapies in Children: A Retrospective Study of 103 Patients from Two Tertiary Haemato-Oncology Referral Centres
por: OLLECH, Ayelet, et al.
Publicado: (2021)

Infliximab in patients with psoriasis and other inflammatory diseases: evaluation of adverse events in the treatment of 168 patients
por: Antonio, João Roberto, et al.
Publicado: (2016)

Adverse Events of Oncologic Immunotherapy and Their Management
por: Barber, Fedricker Diane
Publicado: (2019)

Neurologic adverse events of cancer immunotherapy
por: de Brito, Marcelo Houat
Publicado: (2022)

Placebo-Related Adverse Events in Rheumatoid Arthritis
por: Sharma, Ratna Shree, et al.
Publicado: (2022)

The Immune System’s Echo: The Phenomenon of Delayed Neurological Immune-Related Adverse Events (NirAEs) in Adjuvant Immunotherapy
por: Gohel, Shruti, et al.
Publicado: (2023)

Analysis of Human Performance Deficiencies Associated With Surgical Adverse Events
por: Suliburk, James W., et al.
Publicado: (2019)

Association of Oral Corticosteroid Bursts With Severe Adverse Events in Children
por: Yao, Tsung-Chieh, et al.
Publicado: (2021)

Association of Prior Intracerebral Hemorrhage With Major Adverse Cardiovascular Events
por: Gaist, David, et al.
Publicado: (2022)

Adverse Event Reporting in Randomized Clinical Trials for Multiple Myeloma
por: Najjar, Mimi, et al.
Publicado: (2023)

Desmoid tumour in an inguinal hernia in a patient with a previous diagnosis of melanoma
por: Tissera, Natalia, et al.
Publicado: (2022)

Cost per Event Averted in Cancer Trials in the Adjuvant Setting From 2018 to 2022
por: Mousavi, Idine, et al.
Publicado: (2022)

Musculoskeletal Adverse Events Associated with Adjuvant Aromatase Inhibitors
por: Khan, Qamar J., et al.
Publicado: (2010)

Rheumatological Adverse Events Following Immunotherapy for Cancer
por: Cretu, Ioana, et al.
Publicado: (2022)

Adverse Pregnancy Outcomes and Incident Heart Failure in the Women’s Health Initiative
por: Hansen, Aleksander L., et al.
Publicado: (2021)

Association Between Immune-Related Adverse Events and Recurrence-Free Survival Among Patients With Stage III Melanoma Randomized to Receive Pembrolizumab or Placebo: A Secondary Analysis of a Randomized Clinical Trial
por: Eggermont, Alexander M. M., et al.
Publicado: (2020)

Association of Rituximab Use With Adverse Events in Children, Adolescents, and Young Adults
por: McAtee, Casey Lee, et al.
Publicado: (2021)

Prevalence of Antiphospholipid Antibodies and Association With Incident Cardiovascular Events
por: Zuo, Yu, et al.
Publicado: (2023)

Major adverse cardiac events and drug-coated balloon size in coronary interventions
por: Naguib, David, et al.
Publicado: (2018)

Cardiac rehabilitation performance predicts 1‐year major adverse cardiovascular events
por: Naami, Robert, et al.
Publicado: (2022)

Understanding adverse events of immunotherapy: A mechanistic perspective
por: Burke, Kelly P., et al.
Publicado: (2020)

Immune-related adverse events and the balancing act of immunotherapy
por: Conroy, Michael, et al.
Publicado: (2022)

Emerging Management Approach for the Adverse Events of Immunotherapy of Cancer
por: Rahman, Md. Mominur, et al.
Publicado: (2022)

Assessment of Breast Cancer Mortality Trends Associated With Mammographic Screening and Adjuvant Therapy From 1986 to 2013 in the State of Victoria, Australia
por: Burton, Robert, et al.
Publicado: (2020)

Protocol for analyses of adverse event data from randomized controlled trials of statin therapy
Publicado: (2016)

Association of Gabapentinoids With the Risk of Opioid-Related Adverse Events in Surgical Patients in the United States
por: Bykov, Katsiaryna, et al.
Publicado: (2020)

Trends in Human Papillomavirus Vaccine Safety Concerns and Adverse Event Reporting in the United States
por: Sonawane, Kalyani, et al.
Publicado: (2021)

Identification of Drug Interaction Adverse Events in Patients With COVID-19: A Systematic Review
por: Conti, Valeria, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tijk4053o2im17b73260u0kc5m